Member Login
  1. Stocks
    2. /
  2. Ergomed Plc (LSE: ERGO)
    3. /

LSE:ERGO (Ergomed Plc)

About ERGO

Ergomed Plc is a clinical stage development company, which provides specialist services to the pharmaceutical and biotechnology industries spanning all phases of clinical development, post-approval pharmacovigilance, and medical information. It operates through the following business segments: Clinical Research Services (CRO) and Pharmacovigilance (PV). The CRO segment is engaged in process of developing medical therapies, drugs, and knowledge for safe use in healthcare. The PV segment is involved in the activities relating to the detection, understanding, and prevention of adverse effects or other drug-related problems throughout its lifecycle. The company was founded by Miroslav Reljanovic in 1997 and is headquartered in Guildford, the United Kingdom.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Ergomed Plc (LSE: ERGO) Latest News

    Two gay men are walking through a Victorian shopping arcade
    Investing Articles

    8 shares that Fools have been buying!

    | The Motley Fool Staff

    Our Foolish freelancers are putting their money where their mouths are and buying shares in these equities in recent weeks.

    Read more »

    Investing Articles

    I just bought these beaten-up growth stocks for my ISA

    | Edward Sheldon, CFA

    Edward Sheldon just snapped up two new stocks for his ISA. Both are currently well off their 52-week highs, meaning…

    Read more »

    Silhouette of a bull standing on top of a landscape with the sun setting behind it
    Investing Articles

    3 dirt cheap growth shares to buy right now?

    | Alan Oscroft

    Forget investing in defensive stocks during market weakness, I reckon this is a great time to buy some cheap growth…

    Read more »

    British union jack flag and Parliament house at city of Westminster in the background
    Investing Articles

    3 AIM shares that are worth a look right now

    | Edward Sheldon, CFA

    AIM shares can provide strong returns over the long term. Here, Edward Sheldon highlights three he likes the look of…

    Read more »

    Girl buying groceries in the supermarket with her father.
    Investing Articles

    Just released: the 3 best small-cap stocks to buy now [PREMIUM PICKS]

    | Mark Rogers

    Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

    Read more »

    Genetic Techs with the text “Investing in Genetics Top UK Genetics Stocks in 2022” and The Motley Fool jester cap logo
    Page

    Investing in Genetics: Top UK Genetics Stocks of 2024

    | Zaven Boyrazian, MSc

    Investing in genetics stocks is a risky endeavour. But given industry specialists have and continue to describe this space as…

    Read more »

    Investing Articles

    How I’d look to turn a £1,000 investment in UK growth shares into £5,000

    | Andy Ross

    There are UK growth shares in both the FTSE and AIM markets, contrary to the view of some investors that…

    Read more »

    Investing Articles

    2 UK biotech stocks to watch in 2021

    | Zaven Boyrazian, MSc

    Combined, these two biotech stocks are up 100% over the last 12 months! Zaven Boyrazian takes a closer look at…

    Read more »

    Investing Articles

    Alongside AstraZeneca, I’d buy this small-cap share in the pharmaceutical sector

    | Kevin Godbold

    AstraZeneca’s R&D pipeline is producing new treatments, while this cash-rich small-cap is engaged in studies aimed at treating the symptoms…

    Read more »

    Investing Articles

    AstraZeneca and this small growth pharma stock could make you brilliantly rich

    | Harvey Jones

    Harvey Jones finds a racy little pharma stock to sit beside dividend and growth monster AstraZeneca plc (LON: AZN) in…

    Read more »

    Investing Articles

    GlaxoSmithKline plc isn’t the only pharma stock worth investing in for retirement

    | Peter Stephens

    This company could generate high returns alongside GlaxoSmithKline plc (LON:GSK) (GSK.L).

    Read more »

    Investing Articles

    A small-cap growth stock I’d buy alongside Premier Oil plc in 2018

    | Alan Oscroft

    Premier Oil plc (LON: PMO) could finally be on the up, and here's another potential growth winner I'd buy too.

    Read more »